supported by the Canadian Institutes of Health Research (PJT159735 to Tianru Jin, Canada);supported by China Scholarship Council;supported by Ontario Graduate Scholarship (OGS) Program and the Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Studentship
Since 2005,GLP-1 receptor(GLP-IR)agonists(GLP-IRAs)have been developed as therapeutic agents for type 2 diabetes(T2D).GLP-IR is not only expressed in pancreatic islets but also other organs,especially the lung.However...
supported by the Spanish Ministry of Health(PI17/00828 and Ciberned);Galician Government(XUGA,ED431C 2018/10,ED431G/05);FEDER(Regional European Development Fund),all to AIRP.
In the last decade,attention has become greater to the relationship between neurodegeneration and abnormal insulin signaling in the central nervous system,as insulin in the brain is implicated in neuronal survival,pla...
funded by Xunta de Galicia grant number GRC2013/015 and GPC2017/015(Spain)。
Diabetes mellitus is a major health problem with increasing prevalence at a global level.The discovery of insulin in the early 1900 s represented a major breakthrough in diabetes management,with further milestones bei...
Background:Obesity and insulin resistance(IR)are common features of polycystic ovary syndrome(PCOS).Metformin(MET)increases insulin sensitivity,but it is associated with unsatisfactory weight loss.The glucagon-like pe...
Background: Diabetes mellitus (DM) is a syndrome of chronically elevated glucose level in the blood either due to insulin resistance, insulin deficiency or both. In addition, it may occur due to defec...
Supported by National Natural Science Foundation of China,No.81770776 and No.81973378;Cultivate Scientific Research Excellence Programs of Higher Education Institutions in Shanxi,No.2019KJ022;Special Project for Transformation and Guidance of Scientific and Technological Achievements in Shanxi Province,No.201804D131044.
BACKGROUND Multiple studies demonstrate that fluctuating blood glucose level produces greater damage compared with sustained hyperglycemia.Flash glucose monitoring system is an effective method in documenting blood gl...
funded in part by the German Federal Ministry of Education and Research(BMBF,grant number 03VP03980);supported in part by the Physician Scientist Program of the Faculty of Medicine of Heidelberg University。
Exenatide is the first approved glucagon-like peptide 1 receptor agonist subcutaneously or intramuscularly injected for the treatment of type 2 diabetes mellitus.Typical therapeutic plasma concentrations are in the lo...
the China Postdoctoral Science Foundation(Grant No.2016M602442);the Science and Technology Plan Projects of Guangdong Province(Grant No.2015B020232010);the 111 project(Grant No.B16047);the Natural Science Fund Project of Guangdong Province(Grant No.2018A030310555,Grant No.2016A030312013)。
This study aimed to prepare poly(D, L-lactic-co-glycolic acid) microspheres(PLGA-Ms)by a modified solid-in-oil-in-water(S/O/W) multi-emulsion technique in order to achieve sustained release with reduced initial burst ...
The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1 analogs, brought changes in type 2 diabetes treatment options. For better therapeutic efficiency, these active pharmaceutical ing...